Corticosteroid therapy
Inadequate Timing Between Corticosteroid and Antibiotics Applications Increases Mortality Due to Sepsis
... initiate corticosteroid therapy (inhibiting the macrophage response prior to the release of LPS) before starting antibiotics, and thereby inhibit the otherwise exaggerated response of the ...
7
Rev. Bras. Reumatol. vol.50 número5 en v50n5a03
... Corticosteroid therapy was the initial therapy used (pred- nisone, 1 mg/kg/day, oral) for 4-6 weeks followed by pro- gressive tapering according to clinical and laboratory ...pulse therapy was ...
5
J. bras. pneumol. vol.40 número1
... tiotropium therapy were as follows: systemic corticosteroid therapy, in 8 patients; inhaled corticosteroid therapy, in 7; long-acting β 2 agonist therapy, in 4; methotrexate ...
3
J. Pediatr. (Rio J.) vol.84 número3 en v84n3a03
... of corticosteroid therapy should be gradual, and physicians should be alert for signs and symptoms that could indicate reactivation of the dis- ease, such as signs of joint inflammation, fever, hepatosple- ...
11
Arq. Bras. Cardiol. vol.74 número6
... erythematosus. Corticosteroid therapy has been pointed out as a cause of the increased incidence of systemic hypertension, hyper- cholesterolemia, and probably coronary artery disease 7 ...
5
Arq Bras Endocrinol Metab vol.50 número4
... Postmenopausal women are at greater risk to develop osteoporosis after glucocorticoid exposure, although the pathogenesis in male and female is simi- lar and the therapeutic approaches for women should be the same for ...
9
Maternal haemoglobin and short-term neonatal outcome in preterm neonates.
... antenatal corticosteroid therapy, maternal age, parity and mode of delivery, infants whose mothers had a haemoglobin concentration value within Q1 had a poorer short- term neonatal outcome, whatever their ...
7
J. bras. pneumol. vol.33 número6 en v33n6a20
... The great variety of clinical presentations of IPH, the intermittent nature of the disease and the lack of knowledge regarding the mechanisms involved in its pathogenesis are the greatest chal- lenges we face when trying ...
4
Tacrolimus decreases albuminuria in patients with IgA nephropathy and normal blood pressure: a double-blind randomized controlled trial of efficacy of tacrolimus on IgA nephropathy.
... supportive therapy is the key strategy for IgA nephropathy patients at risk of progression [5], in which the renin- angiotensin-system (RAS) blocker is the most important non- immunosuppressive treatment ...
9
Radiol Bras vol.49 número6
... antifungal therapy was maintained, and corticosteroid therapy was started, resulting in significant clini- cal improvement and regression of the lesions seen on follow-up imaging studies (Figure ...
2
J. bras. pneumol. vol.33 número1 en a18v33n1
... A 56-year-old, white female patient, who was a nonsmoker, sought treatment after experiencing progressive dyspnea and cough for six years. Her condition had deteriorated in the last six months. The patient had been ...
4
PDF EN Jornal Brasileiro de Pneumologia 6 20 english
... The great variety of clinical presentations of IPH, the intermittent nature of the disease and the lack of knowledge regarding the mechanisms involved in its pathogenesis are the greatest chal- lenges we face when trying ...
4
Corticosteroids in acute respiratory distress syndrome
... that corticosteroid will not be effective as ARDS ...tion, corticosteroid therapy may be ineffec- tive if many of the patients that were consid- ered to have ARDS based on clinical defini- tions do ...
13
Rev. bras. ter. intensiva vol.22 número1 en a05v22n1
... diabetes, corticosteroid therapy and delivery; the newborn variables: birth weight, gestation length, Apgar score in the irst and ifth minutes of life, multiple birth, congenital malformations and gender; ...
8
Pediatric Mortality Due to Nosocomial Infection: A Critical Approach
... neutropenia, corticosteroid therapy, multiple organ failure, previous antimicrobial therapy, catheter use duration, candidemia, cancer, bacteremia, age over 60, invasive procedures, mechanical ...
5
Quantification of bone gain in central giant cell granuloma of the jaws submitted to intralesional corticotherapy
... complete corticosteroid intralesional application protocol (six applications in biweekly intervals of triamcinolone ...intralesional corticosteroid therapy, and these tools should be further explored ...
6
Cushing's syndrome in pregnancy: an overview
... medical therapy, metyrapone has been used most often and has had no adverse effects on maternal hepatic function or fetal development in the small number of cases reported to date ...
10
Risk of pneumonia with inhaled corticosteroid versus long-acting bronchodilator regimens in chronic obstructive pulmonary disease: a new-user cohort study.
... inhaled corticosteroid-containing medications including fluticasone propionate, fluticasone propionate/salmeterol in combination, and fluticasone furoate/vilanterol in ...
11
Rev. Bras. Hematol. Hemoter. vol.31 suppl.2
... In the 1990s, the high CR rate and subsequently, the high relapse rate, determined the rationale for the use of high-dose therapy and autologous stem cell transplantation (ASCT) for adult LBL in first CR. Results ...
2
Braz. J. Phys. Ther. vol.11 número4 en a01v11n4
... 1 Rehabilitation Sciences Graduate Program, Physical Therapy Department, Physical Education, Physical. Therapy and Occupational Therapy School – EEFFTO, Federal University of Minas Gera[r] ...
2